Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors

Published:2022-04-18 Issue:7 Volume:27 Page:1164-1172
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Teranishi Ryugo,Takahashi Tsuyoshi^ORCID,Nishida Toshirou,Hirota Seiichi,Kurokawa Yukinori,Saito Takuro,Yamamoto Kazuyoshi,Yamashita Kotaro,Tanaka Koji,Makino Tomoki,Motoori Masaaki,Omori Takeshi,Nakajima Kiyokazu,Eguchi Hidetoshi,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-022-02159-z.pdf

Reference48 articles.

1. DeMatteo RP, Lewis JJ, Leung D et al (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58

2. Steigen SE, Eide TJ (2006) Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 114:192–200

3. Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83

4. Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39:1411–1419

5. Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (New York, NY) 279:577–580

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry;Gastric Cancer;2023-12-25

2. Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report;Surgical Case Reports;2023-04-07

3. The efficacy and adverse events of regorafenib in advanced gastrointestinal stromal tumors after imatinib and sunitinib failure: a systemic review and meta-analysis;2023-01-20

4. The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review;Cureus;2022-09-01

5. Regorafenib;Reactions Weekly;2022-08-13